Abstract
When you face a case of early-onset severe preeclampsia, the definitive treatment is termination of pregnancy, but it is often at the expense of fetal outcome. Thus, expectant management has arisen in the recent literature as a treatment option. As thrombophilia is implicated in many adverse pregnancy outcomes, blood thinners such as heparin and low-dose aspirin have been introduced as a part of expectant management in this article.
Financial & competing interests disclosure
The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.